Saving changes...

Done

Error

Bipolar Disorder Managing the Ups & Downs of a Complex Illness

Bipolar Disorder Managing the Ups & Downs of a Complex Illness

Bipolar Disorder Managing the Ups & Downs of a Complex Illness

Julie Dopheide, Pharm.D.
Julie Dopheide, Pharm.D.
on behalf of University of Texas at Austin College of Pharmacy

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 09 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170990

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Bipolar disorder, sometimes referred to as manic-depressive illness, may be misidentified by health care practitioners as major depression, an anxiety disorder, attention deficit hyperactivity disorder, or even schizophrenia because of the wide range of clinical presentations. 1 National screening studies estimate that the lifetime prevalence of bipolar disorder is approximately 4%, which is higher than schizophrenia at 1% 2 and lower than major depressive disorder at almost 17%. 3-5 Medications used to treat bipolar illness are as wide-ranging as the symptoms. Lithium, anticonvulsants, antipsychotics, benzodiazepines, and antidepressants all have a place in the treatment of individuals with bipolar disorder. 6,7 The challenge is finding the right combination of medication and psychosocial intervention for a given individual. Barriers to Stabilization Lack of insight into the illness and high rates of nonadherence (40-60%) are primary barriers to the stabilization of bipolar illness. 8,9 Up to 60% of those with bipolar disorder abuse drugs and alcohol.10 This greatly contributes to mood instability and nonadherence. The use of antidepressants without mood stabilizers (eg, lithium, valproate) or second-generation antipsychotics (SGA) has been shown to increase the frequency of mood episodes in bipolar illness and lead to mood destabilization. 6,11 The Role of the Community Practitioner The role of the community practitioner is threefold: 1) to recognize symptoms of bipolar disorder and encourage appropriate drug therapy; 2) to counsel patients on bipolar disorder as a highly treatable illness that requires lifelong medication and psychosocial interventions; and 3) to provide medication education and monitoring to ensure maximum therapeutic benefit, prevent drug interactions, and help patients manage medication side effects. Format This CE activity is a monograph (PDF file).

Objectives

Objectives
Describe the diverse clinical presentations of bipolar disorder and explain how this impacts treatment. Recognize appropriate and inappropriate drug treatment for each phase of bipolar illness and recommend drug-specific monitoring parameters. Provide medication counseling to a patient taking lithium, an anticonvulsant, antipsychotic, antidepressant or combination of medications for bipolar illness. Provide education to promote mood stability and avoidance of drug interactions.
Julie Dopheide, Pharm.D.

Author Information Play Video Bio

Julie Dopheide, Pharm.D.
on behalf of University of Texas at Austin College of Pharmacy

Julie A. Dopheide, PharmD, BCPP, FASHP is a Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy and the Keck School of Medicine in Los Angeles, California

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.50 Hours -
    Reference: 0428-0000-15-007-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error